GlassScriptPhysician profile
Meghan M Weir
NPI 1174798748
$1,587.38
in general payments reported to CMS, 2019-2025
21 companies · $527 in 2025
The $527 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.64 · 2023: $319 · 2024: $724 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $162.58 | 2023-2025 | |
| Ironshore Pharmaceuticals INC. | $147.32 | 2023-2024 | Jornay Pm |
| Sobi, INC | $140.98 | 2023-2024 | |
| Corium, LLC | $128.33 | 2024-2025 | Azstarys |
| Seqirus USA INC | $127.01 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $117.03 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $111.79 | 2023-2025 | |
| Cranial Technologies, INC | $92.74 | 2024-2025 | Doc Band |
| Organon LLC | $86.68 | 2024-2025 | Nexplanon |
| Baxter Healthcare | $75.47 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $67.60 | 2024-2025 | |
| Vertical Pharmaceuticals, LLC | $46.21 | 2024-2025 | Relexxii |
| Kaleo, INC. | $44.79 | 2024 | Auvi-Q |
| Exeltis, USA INC. | $44.59 | 2025 | Slynd |
| Astrazeneca Pharmaceuticals LP | $41.58 | 2023-2024 | Flumist Quadrivalent |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $36.55 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $32.57 | 2022-2024 | M-M-R II, Gardasil 9, Gardasil |
| Tempus Ai, INC | $29.75 | 2024 | |
| Glaxosmithkline, LLC. | $24.85 | 2023 | Rotarix, Bexsero |
| Verrica Pharmaceuticals INC. | $16.20 | 2024 | Ycanth |
| Nestle Healthcare Nutrition INC. | $12.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Weir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.